Sugi Predict

Sugi Predict / Compounds / SCHEMBL111479

SCHEMBL111479

SCHEMBL111479

CCC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.70
▸ KDM4E B2RXH2 5/20 0.69
▸ POLB P06746 1/20 0.69
▸ ALDH1A1 P00352 6/20 0.67
▸ SMN1; SMN2 Q16637 5/20 0.67
▸ NPC1 O15118 4/20 0.67
▸ RAB9A P51151 4/20 0.67
▸ HPGD P15428 3/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ LMNA P02545 4/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ RECQL P46063 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ CTSK P43235 1/20 0.59
▸ ABCC1 P33527 1/20 0.59
▸ HCAR2 Q8TDS4 1/20 0.57
▸ HTT P42858 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29543730 1.00 KMT2A (0.70) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
Phenol SCHEMBL28121926 0.95 KMT2A (0.64) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL10035491 0.90 KMT2A (0.71) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL13623623 0.87 ALDH1A1 (0.64) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL10501327 0.86 KMT2A (0.83) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL2968441 0.86 KMT2A (0.66) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL3358264 0.85 ALDH1A1 (0.62) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL5189053 0.85 ALDH1A1 (0.62) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL637658 0.85 ALDH1A1 (0.62) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL16404495 0.85 KMT2A (0.69) KMT2AKDM4EPOLBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205458-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-26 — — WO claimed
US-9770397-B2 Oxidative dyeing composition KAO GERMANY GMBH (DE) 2017-09-26 — — US claimed
EP-3113754-A1 OXIDATIVE DYEING COMPOSITION Kao Germany GmbH (DE) 2017-01-11 — — EP claimed
US-20160184205-A1 OXIDATIVE DYEING COMPOSITION KAO GERMANY GMBH (DE) 2016-06-30 — — US claimed
WO-2015180740-A1 OXIDATIVE DYEING COMPOSITION KAO GERMANY GMBH (DE) 2015-12-03 — — WO claimed
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SYMRISE AG (DE) 2026-03-17 — — US disclosed
US-12564551-B2 Composition or oat extract comprising avenanthramide and β-glucan SYMRISE AG (DE) 2026-03-03 — — US disclosed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 — — US disclosed
US-12534685-B2 Fragrance composition SYMRISE AG (DE) 2026-01-27 — — US disclosed
US-20250332078-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABINOIDS SYMRISE AG (DE) 2025-10-30 — — US disclosed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 — — US disclosed
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound SYMRISE AG (DE) 2025-08-28 — — US disclosed
WO-2004111014-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-12-23 — — WO disclosed
CN-1129587-C Saccharin deriv. BASF AG (DE) 2003-12-03 — — CN disclosed
CN-1059207-C Herbicidal saccharin carboxylic and its ester defivatives and method for their prep. BASF AG (DE) 2000-12-06 — — CN disclosed
CN-1058007-C Saccharine derivatives BASF AG (DE) 2000-11-01 — — CN disclosed
CN-1159189-A Preparation of saccharine carboxylic acids and esters BASF AG (DE) 1997-09-10 — — CN disclosed
CN-1158124-A Saccharine derivatives BASF AG (DE) 1997-08-27 — — CN disclosed
CN-1157616-A 5-Hydroxypyrazol-4-ylcarbonyl-substituted saccharin derivatives BASF AG (DE) 1997-08-20 — — CN disclosed
CN-1059722-A 3-aryl-4 (3H) quinazolinone CCK peptide antagonists and pharmaceutical preparation thereof LLI LILLY AND CO (US) 1992-03-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound GK, DAGLA, KAT5 KMT2A 591/4885KDM4E 66/4885POLB 2719/4885
US-12534685-B2 Fragrance composition NCLN, HCN2, TRPA1 KMT2A 2417/4885KDM4E 1609/4885POLB 735/4885
US-20160184205-A1 OXIDATIVE DYEING COMPOSITION POR, CYP4A22, CYP3A43 KMT2A 2343/4885KDM4E 3492/4885POLB 393/4885
US-12564551-B2 Composition or oat extract comprising avenanthramide and β-glucan CUTA, HLA-A, OAT KMT2A 2657/4885KDM4E 4062/4885POLB 1511/4885
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 KMT2A 3030/4885KDM4E 4297/4885POLB 2297/4885
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SCD5, SMURF1, SGMS1 KMT2A 4733/4885KDM4E 1676/4885POLB 779/4885
US-20250332078-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABINOIDS CNR2, CNR1, PHOSPHO1 KMT2A 1596/4885KDM4E 1737/4885POLB 492/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 KMT2A 2977/4885KDM4E 2903/4885POLB 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.